All Cases

Neurology / Psychiatry

Product development and commercialization support for an imaging biomarker in Alzheimer’s

Commercial development and operations for a novel retinal imaging biomarker in multiple sclerosis (MS)

Post-merger portfolio and commercialization integration for a mid-size Neurology company

Assessed new pain portfolio product lines, for potential update in the Middle East, Central America, and North Africa.

Revised value proposition to support launch of a small molecule in a second indication

Constructed a value proposition and IMSS (Mexico) access plan for a novel multiple sclerosis (MS) therapy

Strategic positioning of a Parkinson’s Disease therapy being launched in US and EU

Commercial root cause analysis and revised, enhanced commercial strategy for a Parkinson’s Disease treatment

Characterized and segmented the treatment ecosystem for relapsing multiple sclerosis (MS) to inform patient- and ecosystem-support strategies and promote a robust launch for a small biotech

Assessed challenges to improve the quality of multiple sclerosis care in LATAM for a large pharmaceutical company looking to publish a position paper to guide the improvement of care for these patients